* DarioHealth Corp DRIO.OQ reported a quarterly adjusted
loss
of 74 cents per share for the quarter ended in June. The mean
expectation of eight analysts for the quarter was for a loss
of 71 cents per share.
* Revenue rose 17.5% to $6.18 million from a year ago;
analysts
expected $8.24 million.
* DarioHealth Corp's reported EPS for the quarter was a loss
of 82
cents.
* The mean earnings estimate of analysts had risen by
about 6.3%
in the last three months.
* In the last 30 days there have been no negative revisions
of
earnings estimates
* DarioHealth Corp shares had risen by 16.6% this
quarter and
lost 44.8% so far this year.
* The company reported a quarterly loss of $18.46 million.
* Wall Street's median 12-month price target for DarioHealth
Corp
is $18.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data August 15
at 12:00 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 -0.71 -0.74 Missed
Mar. 31 2022 -0.96 -0.74 Beat
Dec. 31 2021 -1.06 -1.09 Missed
Sep. 30 2021 -0.94 -1.18 Missed